Ensysce Biosciences (ENSC) Cash from Financing Activities (2018 - 2025)
Ensysce Biosciences (ENSC) reported Cash from Financing Activities of $1.45 million for Q3 2025, down 64.9% from $4.13 million a year earlier and down 22.2% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Cash from Financing Activities (2018 - 2025) Analysis & Trends
Over the twelve months ended Sep 30, 2025, Ensysce Biosciences' Cash from Financing Activities came in at $4.69 million, down 58.3% year-over-year; for FY2024, it came in at $9.88 million, up 12.9% from FY2023.
- By year, Cash from Financing Activities came in at $8.76 million in FY2023 (-0.1%), $8.77 million in FY2022 (-56.8%), $20.31 million in FY2021 and $1.1 million in FY2020.
- Five-year quarterly Cash from Financing Activities spans a low of -$391,270 in Q1 2022 and a high of $9.19 million in Q4 2021.
- Year over year, Cash from Financing Activities gained in 1 of the last five quarters, with an average decline of 11.3%.
- The high point for year-over-year Cash from Financing Activities in five years was Q3 2021 (growth of 786.3%); the low point was Q2 2021 (a decline of 94.2%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $1.87 million (Q2 2025), $1.26 million (Q1 2025) and $112,575 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Ensysce Biosciences | 1.07 Mn | -10.50 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 112,575.00 |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | -51,227.00 |
| Mar 31, 2024 | 5.69 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | -102,455.00 |
| Jun 30, 2023 | 5.52 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | 1.94 Mn |
| Sep 30, 2022 | 7.48 Mn |
| Jun 30, 2022 | -265,812.00 |
| Mar 31, 2022 | -391,270.00 |
| Dec 31, 2021 | 9.19 Mn |
| Sep 30, 2021 | 2.66 Mn |
| Jun 30, 2021 | 7.85 Mn |
| Mar 31, 2021 | 612,862.00 |
| Sep 30, 2020 | 300,000.00 |
API Access
Ensysce Biosciences Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();